Featured News

The Voluntary Recommendations for Managing Celiac Disease in Learning Environments provides definitive guidance for schools, parents and caregivers for 504 accommodations for children with celiac disease. Download the guide and watch the video.

TAK-062, an orally administered synthetic enzyme that survives the acidity of the stomach and digests gluten effectively, has passed its phase 1 clinical drug trial, indicating it is safe to use in celiac patients.

Showcasing the “brightest ideas and breakthroughs in digestive disease,” DDW 2020 includes recent studies and innovations in celiac disease and gluten-related disorders, some of which we have curated and summarized for you.

A small pilot study suggests chemical pollutants might be an environmental factor associated with celiac disease in children. This is the first research to link the autoimmune disorder with persistent organic pollutants (POPs) detected in blood samples from celiac patients.

The Celiac Disease Foundation joins with the world organizations to assure that vital health-saving information for celiac patients continues to be available. Stronger together in the face of crisis, this May Celiac Awareness Month, share the #CeliacUnited campaign on your social media channels.

 Today is Giving Tuesday Now, a global day of unity and action to support nonprofit organizations struggling with the economic impact of COVID-19. Every donation gets us one step closer to treatments and a cure and will be rewarded with delicious gluten-free goodies.

2020 marks the 30th Anniversary for the Celiac Disease Foundation. We're celebrating 30 years with a highlight reel of CDF's most notable yearly accomplishments, posted each day throughout the month of May on CDF’s Facebook & Twitter.

May is Celiac Disease Awareness Month - the perfect time to join the Celiac Disease Foundation in generating support for research for treatments and a cure! Raise or Donate between May 1 - May 31 and receive gluten-free products from Proud Sponsor Schar.

Confronted with the reality of an all-consuming global pandemic, every nonprofit, including the Celiac Disease Foundation, has to figure out where we fit in a world that is quickly changing and into a future that no one can predict.

The first mice with characteristics of celiac disease have been developed at the University of Chicago Celiac Disease Center. For the first time researchers can observe celiac disease onset as the mouse’s immune system launches a coordinated attack against gluten.